🎉 M&A multiples are live!
Check it out!

EBM Technologies Valuation Multiples

Discover revenue and EBITDA valuation multiples for EBM Technologies and similar public comparables like Healius, Cyclopharm, and CurveBeam AI.

EBM Technologies Overview

About EBM Technologies

EBM Technologies Inc is engaged in picture archiving and communication systems. Its products include EBM diagnostic and reviewing station, EBM storage and utility server, and EBM breast imaging for PACS. The company develops and markets medical information technology solutions; and provides to the health sector.


Founded

1988

HQ

Taiwan
Employees

116

Website

ebmtech.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$16.6M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

EBM Technologies Financials

EBM Technologies has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, EBM Technologies achieved revenue of $8.5M and an EBITDA of $0.7M.

EBM Technologies expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See EBM Technologies valuation multiples based on analyst estimates

EBM Technologies P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $6.2M $8.5M XXX XXX XXX
Gross Profit $5.6M $4.7M XXX XXX XXX
Gross Margin 89% 55% XXX XXX XXX
EBITDA $0.1M $0.7M XXX XXX XXX
EBITDA Margin 2% 8% XXX XXX XXX
Net Profit $0.1M -$0.4M XXX XXX XXX
Net Margin 2% -5% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

EBM Technologies Stock Performance

As of April 15, 2025, EBM Technologies's stock price is TWD 22 (or $1).

EBM Technologies has current market cap of TWD 688M (or $20.8M), and EV of TWD 548M (or $16.6M).

See EBM Technologies trading valuation data

EBM Technologies Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$16.6M $20.8M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

EBM Technologies Valuation Multiples

As of April 15, 2025, EBM Technologies has market cap of $20.8M and EV of $16.6M.

EBM Technologies's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate EBM Technologies's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for EBM Technologies and 10K+ public comps

EBM Technologies Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $16.6M XXX XXX XXX
EV/Revenue 2.0x XXX XXX XXX
EV/EBITDA 23.8x XXX XXX XXX
P/E 321.5x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 4.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get EBM Technologies Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

EBM Technologies Valuation Multiples

EBM Technologies's NTM/LTM revenue growth is n/a

EBM Technologies's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $45K for the same period.

Over next 12 months, EBM Technologies's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate EBM Technologies's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for EBM Technologies and other 10K+ public comps

EBM Technologies Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 36% XXX XXX XXX XXX
EBITDA Margin 8% XXX XXX XXX XXX
EBITDA Growth 511% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $45K XXX XXX XXX XXX
S&M Expenses to Revenue 21% XXX XXX XXX XXX
G&A Expenses to Revenue 22% XXX XXX XXX XXX
R&D Expenses to Revenue 18% XXX XXX XXX XXX
Opex to Revenue 62% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

EBM Technologies Public Comps

See public comps and valuation multiples for Medical Imaging & Diagnostics and Healthcare Software comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Australian Clinical Labs XXX XXX XXX XXX XXX XXX
Clarity Pharmaceuticals XXX XXX XXX XXX XXX XXX
CurveBeam AI XXX XXX XXX XXX XXX XXX
Cyclopharm XXX XXX XXX XXX XXX XXX
Healius XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

EBM Technologies M&A and Investment Activity

EBM Technologies acquired  XXX companies to date.

Last acquisition by EBM Technologies was  XXXXXXXX, XXXXX XXXXX XXXXXX . EBM Technologies acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by EBM Technologies

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About EBM Technologies

When was EBM Technologies founded? EBM Technologies was founded in 1988.
Where is EBM Technologies headquartered? EBM Technologies is headquartered in Taiwan.
How many employees does EBM Technologies have? As of today, EBM Technologies has 116 employees.
Is EBM Technologies publicy listed? Yes, EBM Technologies is a public company listed on ROCO.
What is the stock symbol of EBM Technologies? EBM Technologies trades under 8409 ticker.
When did EBM Technologies go public? EBM Technologies went public in 2012.
Who are competitors of EBM Technologies? Similar companies to EBM Technologies include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm.
What is the current market cap of EBM Technologies? EBM Technologies's current market cap is $20.8M
What is the current revenue growth of EBM Technologies? EBM Technologies revenue growth between 2023 and 2024 was 36%.
Is EBM Technologies profitable? Yes, EBM Technologies is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.